Literature DB >> 11013385

Significantly increased lesion size by using the near-infrared photosensitizer 5,10,15,20-tetrakis (m-hydroxyphenyl)bacteriochlorin in interstitial photodynamic therapy of normal rat liver tissue.

J P Rovers1, M L de Jode, M F Grahn.   

Abstract

BACKGROUND AND
OBJECTIVE: Penetration of tissues by activating light ultimately limits the size of the lesions achievable in interstitial photodynamic therapy. Measurements of the wavelength-dependence of tissue optical properties suggest that substantial improvements may be possible, particularly in pigmented organs such as the liver, by using drugs absorbing at near infrared wavelengths. STUDY DESIGN/
MATERIALS AND METHODS: In this study, the extent of light induced necrosis with the photosensitive agents Photofrin (activated at 632 nm), meta-tetra(hydroxyphenyl)chlorin (mTHPC) (activated at 652 nm) and 5,10,15,20-tetrakis(m-hydroxyphenyl)bacteriochlorin (mTHPBC) (activated at 740 nm) are compared in normal rat liver. Interstitial irradiation of mTHPBC-sensitized liver tissue resulted in significantly larger necrotic areas than irradiation of Photofrin and mTHPC-sensitised livers.
CONCLUSION: The results illustrate the advantage of near-infrared photosensitizer activation and point to a specific role for mTHPBC in the interstitial treatment of liver tumours. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11013385     DOI: 10.1002/1096-9101(2000)27:3<235::aid-lsm5>3.0.co;2-t

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  6 in total

1.  Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers.

Authors:  Liyi Huang; Ying-Ying Huang; Pawel Mroz; George P Tegos; Timur Zhiyentayev; Sulbha K Sharma; Zongshun Lu; Thiagarajan Balasubramanian; Michael Krayer; Christian Ruzié; Eunkyung Yang; Hooi Ling Kee; Christine Kirmaier; James R Diers; David F Bocian; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

2.  Optimal treatment opportunity for mTHPC-mediated photodynamic therapy of liver cancer.

Authors:  Jian-dong Wang; Jun Shen; Xue-ping Zhou; Wei-bin Shi; Jiang-hua Yan; Fang-hong Luo; Zhi-wei Quan
Journal:  Lasers Med Sci       Date:  2013-02-03       Impact factor: 3.161

3.  X-ray induced photodynamic therapy with copper-cysteamine nanoparticles in mice tumors.

Authors:  Samana Shrestha; Jing Wu; Bindeshwar Sah; Adam Vanasse; Leon N Cooper; Lun Ma; Gen Li; Huibin Zheng; Wei Chen; Michael P Antosh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-01       Impact factor: 11.205

Review 4.  Interstitial photodynamic laser therapy in interventional oncology.

Authors:  Thomas J Vogl; Katrin Eichler; Martin G Mack; Stephan Zangos; Christopher Herzog; Axel Thalhammer; Kerstin Engelmann
Journal:  Eur Radiol       Date:  2004-03-26       Impact factor: 5.315

5.  Preparation and evaluation of 99mTc-labeled porphyrin complexes prepared using PNP and HYNIC cores: studying the effects of core selection on pharmacokinetics and tumor uptake in a mouse model.

Authors:  Mohini Guleria; Tapas Das; Kusum Vats; Jeyachitra Amirdhanayagam; Anupam Mathur; Haladhar D Sarma; Ashutosh Dash
Journal:  Medchemcomm       Date:  2019-02-22       Impact factor: 3.597

6.  Selectivity of the photosensitiser Tookad for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model.

Authors:  F Borle; A Radu; C Fontolliet; H van den Bergh; P Monnier; G Wagnières
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.